AU Stock MarketDetailed Quotes

BXN Bioxyne Ltd

Watchlist
  • 0.026
  • +0.003+13.04%
20min DelayMarket Closed Dec 24 13:54 AET
53.28MMarket Cap-3.71P/E (Static)

About Bioxyne Ltd Company

Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments namely, wholesale sales, Plant-based, Manufacturing sales, and direct sales. The majority of the revenue is generated from plants based segment.

Company Profile

SymbolBXN
Company NameBioxyne Ltd
Founded1998
MarketASX
Employees16
Fiscal Year Ends06-30
Address50 Clarence Street Suite 506, Level 5
CitySydney
CountryAustralia
Zip Code2000
Phone+61 290787669
Share RegistryAUTOMIC REGISTRY SERVICES Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000 02 9698 5414

Company Executives

  • Name
  • Position
  • Salary
  • Samuel Watson
  • Chief Executive Officer,Managing Director
  • --
  • Anthony (Tony) Peng Ho
  • Non-Executive Director,Non-Executive Chairman
  • --
  • Jason Hine
  • Non-Executive Director
  • --